Notes / Company

Eiko Lifesciences Ltd.

EIKO BSE 540204 ISIN INE666Q01016 Chemicals

Fundamentals

Market cap: ₹71.71 cr
P/E: 15.95×
ROE: 3.71%
Debt / equity: 0.05
52-week range: 45.90 — 65.90

Research on Tijori Finance

The timeline — 1 note on Eiko Lifesciences Ltd.

May 2026

26 May 26 · 1:29 PM IST Brief

Brief · Earnings · Micro cap

Eiko Lifesciences revenue jumps 124% in Q4

The company reported a strong finish to FY26 with standalone revenue growth of 124% YoY for the quarter and a doubling of net profit.

Verify on exchange BSE filings for EIKO NSE filings for EIKO Tijori Finance company page